Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HSM
Helius Medical Technologies
C$0.00
C$14.26
C$40.00
C$42.54MN/A3,578 shs930 shs
MedX Health Corp stock logo
MDX
MedX Health
C$0.05
-10.0%
C$0.05
C$0.04
C$0.07
C$16.40M0.34199586,563 shs6,000 shs
PulteGroup, Inc. stock logo
PHM
PulteGroup
$124.68
+0.3%
$128.73
$108.49
$144.49
$23.30B1.191.22 million shs922,396 shs
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
$82.21
+0.2%
$83.37
$81.17
$92.18
$41.41B0.5131.94 million shs16.51 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HSM
Helius Medical Technologies
0.00%0.00%0.00%0.00%0.00%
MedX Health Corp stock logo
MDX
MedX Health
+11.11%+11.11%-9.09%-9.09%-28.57%
PulteGroup, Inc. stock logo
PHM
PulteGroup
+0.42%-2.08%-5.72%+4.76%-6.87%
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
+0.15%-1.28%-0.91%-3.52%-5.20%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HSM
Helius Medical Technologies
C$0.00
C$14.26
C$40.00
C$42.54MN/A3,578 shs930 shs
MedX Health Corp stock logo
MDX
MedX Health
C$0.05
-10.0%
C$0.05
C$0.04
C$0.07
C$16.40M0.34199586,563 shs6,000 shs
PulteGroup, Inc. stock logo
PHM
PulteGroup
$124.68
+0.3%
$128.73
$108.49
$144.49
$23.30B1.191.22 million shs922,396 shs
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
$82.21
+0.2%
$83.37
$81.17
$92.18
$41.41B0.5131.94 million shs16.51 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HSM
Helius Medical Technologies
0.00%0.00%0.00%0.00%0.00%
MedX Health Corp stock logo
MDX
MedX Health
+11.11%+11.11%-9.09%-9.09%-28.57%
PulteGroup, Inc. stock logo
PHM
PulteGroup
+0.42%-2.08%-5.72%+4.76%-6.87%
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
+0.15%-1.28%-0.91%-3.52%-5.20%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HSM
Helius Medical Technologies
0.00
N/AN/AN/A
MedX Health Corp stock logo
MDX
MedX Health
0.00
N/AN/AN/A
PulteGroup, Inc. stock logo
PHM
PulteGroup
2.72
Moderate Buy$142.2014.05% Upside
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest MDX, TLT, PHM, and HSM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/24/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
Set Price TargetPeer PerformOutperform$129.00
8/24/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
UpgradePeer PerformOutperform$158.00
8/21/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
UpgradeHold (C+)Buy (B-)
8/18/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
Reiterated RatingMarket Outperform
7/24/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
Lower Price TargetNeutral$138.00 ➝ $134.00
7/23/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
UpgradeHold (C)Hold (C+)
7/23/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
Reiterated RatingBuy$166.00
7/23/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
Boost Price TargetSector Perform$115.00 ➝ $116.00
7/23/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
Reiterated RatingOutperform$162.00
7/23/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
Boost Price TargetEqual Weight$123.00 ➝ $124.00
(Data available from 9/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HSM
Helius Medical Technologies
C$477K0.00N/A5.71C$3.61 per share0.00
MedX Health Corp stock logo
MDX
MedX Health
C$569.79K25.90C$0.00 per share60.00C($0.03) per share-1.50
PulteGroup, Inc. stock logo
PHM
PulteGroup
$17.31B1.35$12.65 per share9.86$69.42 per share1.80
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HSM
Helius Medical Technologies
N/A-C$11.02N/AN/AN/AN/AN/AN/AN/A
MedX Health Corp stock logo
MDX
MedX Health
-C$3.82M-C$0.02N/AN/AN/AN/AN/A-220.68%N/A
PulteGroup, Inc. stock logo
PHM
PulteGroup
$2.22B$9.7912.7411.221.5411.62%15.21%10.89%10/22/2026 (Estimated)
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest MDX, TLT, PHM, and HSM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/22/2026Q2 2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
$2.36$2.48+$0.12$2.48$3.94 billion$3.98 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
HSM
Helius Medical Technologies
N/AN/AN/AN/AN/A
MedX Health Corp stock logo
MDX
MedX Health
N/AN/AN/AN/AN/A
PulteGroup, Inc. stock logo
PHM
PulteGroup
$1.040.83%+12.97%10.62%7 Years
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
$4.215.12%N/AN/AN/A

Latest MDX, TLT, PHM, and HSM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/2/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
quarterly$0.260.84%9/15/20269/15/202610/2/2026
8/31/2026
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
monthly$0.31474.61%9/1/20269/1/20269/4/2026
7/31/2026
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
monthly$0.33054.82%8/3/20268/3/20268/6/2026
6/30/2026
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
Monthly$0.31804.46%7/1/20267/1/20267/7/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
HSM
Helius Medical Technologies
0.74
4.20
3.58
MedX Health Corp stock logo
MDX
MedX Health
N/A
0.10
0.05
PulteGroup, Inc. stock logo
PHM
PulteGroup
0.14
0.78
0.78
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
HSM
Helius Medical Technologies
N/A
MedX Health Corp stock logo
MDX
MedX Health
3.04%
PulteGroup, Inc. stock logo
PHM
PulteGroup
89.90%
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
73.33%
CompanyEmployeesShares OutstandingFree FloatOptionable
HSM
Helius Medical Technologies
192.32 millionN/ANot Optionable
MedX Health Corp stock logo
MDX
MedX Health
N/A327.93 millionN/ANot Optionable
PulteGroup, Inc. stock logo
PHM
PulteGroup
6,506187.45 million186.05 millionOptionable
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
N/A503.70 millionN/AOptionable

Recent News About These Companies

Recent Yen Rally Puts These 3 ETFs in Focus
Labor Shock: 162,000 Jobs, But This Is No Hiring Boom
The Bond Market Might Be Getting Out Of Control
Don't Short the Bond Rout, Expert Sees a Better Trade
This September Feels Very Different
Oil Prices Push Global Bond Market Closer to the Edge
ETF Asset Flow of August: S&P 500 Tops
Some TIPS ETFs Disappoint. This One Doesn't.
A Few Factors to Check Before Buying Bond ETFs
The Death Of The Dollar
TLT: AI Productivity Gains Threaten Long-End Treasuries
Computer monitor on a desk displaying a candlestick stock price chart showing a decline followed by an upward rebound.
3 Contrarian Trades for a Market That Looks Too Hot (TLT)
...

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines

Helius Medical Technologies TSE:HSM

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

MedX Health stock logo

MedX Health CVE:MDX

C$0.04 -0.01 (-10.00%)
As of 02:16 PM Eastern

MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.

PulteGroup stock logo

PulteGroup NYSE:PHM

$124.68 +0.37 (+0.30%)
As of 03:58 PM Eastern

PulteGroup, Inc., through its subsidiaries, primarily engages in the homebuilding business in the United States. It acquires and develops land primarily for residential purposes; and constructs housing on such land. The company also offers various home designs, including single-family detached, townhomes, condominiums, and duplexes under the Centex, Pulte Homes, Del Webb, DiVosta Homes, John Wieland Homes and Neighborhoods, and American West brand names. In addition, the company arranges financing through the origination of mortgage loans primarily for homebuyers; sells the servicing rights for the originated loans; and provides title insurance policies, and examination and closing services to homebuyers. PulteGroup, Inc. was founded in 1950 and is headquartered in Atlanta, Georgia.

iShares 20+ Year Treasury Bond ETF stock logo

iShares 20+ Year Treasury Bond ETF NASDAQ:TLT

$82.21 +0.14 (+0.17%)
As of 04:00 PM Eastern

iShares 20+ Year Treasury Bond ETF (the Fund) is an exchange-traded fund. The Fund seeks to track the investment results of an index composed of United States Treasury bonds with remaining maturities greater than 20 years. The Fund seeks to track the investment results of the Barclays U.S. 20+ Year Treasury Bond Index (the Underlying Index), which measures the performance of public obligations of the United States Treasury that have a remaining maturity of 20 or more years. The Underlying Index includes all publicly-issued the United States Treasury securities that have a remaining maturity of greater than or equal to 20 years. BlackRock Fund Advisors serves as investment adviser of the Fund.